Salicylic acid

Description

Wart Remover Pads are a topical dosage form designed for the removal of warts. These pads contain active ingredients that facilitate the treatment of common warts. The product is formulated for direct application to the affected area, providing a convenient method for wart management. The pads are typically characterized by their adhesive backing, allowing for secure placement on the skin.

Uses and Indications

This drug is indicated for the removal of warts.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals are advised to administer one patch of tolnaftate per day. Each patch contains 1 mg of tolnaftate. The patch should be applied to clean, dry skin, ensuring that it adheres properly. It is important to rotate the application site with each new patch to minimize skin irritation.

Contraindications

Use is contraindicated in the following situations:

Application on irritated, infected, or reddened skin is prohibited due to the potential for exacerbating the condition. The product should not be applied to genital warts or warts located on the face, as these areas may be particularly sensitive and at risk for adverse reactions. Additionally, the use of this product on moles, birthmarks, or warts with hair growing from them on mucous membranes is contraindicated to prevent complications and ensure patient safety.

Warnings and Precautions

For external use only. It is imperative to keep this product out of reach of children to prevent accidental ingestion or misuse.

The product should not be applied to irritated, infected, or reddened skin. Additionally, it is contraindicated for use on genital warts, warts located on the face, moles, birthmarks, and warts with hair growing from them, particularly on mucous membranes.

Healthcare professionals should advise patients to consult a doctor prior to use if they have diabetes or experience poor blood circulation, as these conditions may increase the risk of adverse effects.

In the event of accidental ingestion, immediate medical assistance should be sought, or the individual should contact a Poison Control Center without delay.

Side Effects

Patients should be aware that the product is intended for external use only. In the event of accidental ingestion, it is crucial to seek medical assistance immediately or contact a Poison Control Center for guidance. This precaution is essential to ensure the safety and well-being of individuals using the product.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Remover Pads. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare provider prior to use. Potential risks to the fetus are not clearly defined, and caution is advised. There are no specific dosage modifications for pregnant individuals provided in the prescribing information. It is recommended that women of childbearing potential discuss the use of this product with a healthcare professional before initiating treatment during pregnancy.

Lactation

There is no specific information available regarding the use of this medication in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication. It is recommended to weigh the potential benefits against any unknown risks to the nursing infant.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the patient's clinical presentation. Continuous evaluation and appropriate interventions should be implemented as necessary to ensure patient safety and recovery.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion.

Patients should be instructed to consult with their healthcare provider before using the medication if they have diabetes or poor blood circulation, as these conditions may require special consideration.

In the event that the medication is swallowed, patients must be informed to seek medical help or contact a Poison Control Center immediately. This prompt action is crucial for ensuring patient safety and effective management of any potential adverse effects.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within the temperature range of 59°F to 86°F (15°C to 30°C) to maintain its efficacy and integrity. Proper storage conditions must be adhered to, ensuring that the product is kept in a suitable environment to prevent degradation.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Wart Remover Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)